Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Physiomics Share Price
  4. Physiomics Share News
  5. IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Pin to quick picksPhysiomics Share News (PYC)

Physiomics Information

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Tue, 11th May 2021 17:50

Physiomics PLC - oncology consultant based in Oxford - Awarded its first contract by Zurich-based biopharmaceutical company Numab Therapeutics, which is focused on developing biotherapeutics for chronic inflammation and cancer.

"We are delighted that Numab has selected Physiomics to support them with one of their new programs and look forward to working with their highly talented team," notes Chief Executive Officer Jim Millen.

Current stock price: 5.91 pence

Year-to-date change: down 20%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
31 May 2023 11:57

Physiomics to work with University of Sheffield on cancer research

(Alliance News) - Physiomics PLC on Wednesday said it will collaborate with the University of Sheffield on research into an insect model of cancer treatment.

Read more
23 May 2023 12:17

Physiomics shares drop after it cuts full-year guidance

(Alliance News) - Physiomics PLC shares fell on Tuesday, after it lowered its full-year outlook by more than 10%.

Read more
23 May 2023 10:32

AIM WINNERS & LOSERS: Physiomics falls as lowers full-year guidance

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
26 Apr 2023 14:32

TRADING UPDATES: Narf Industries audit delay; Arecor wins patent

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
26 Apr 2023 13:17

Physiomics inks collaboration deal with ValiRx subsidiary

(Sharecast News) - Physiomics announced on Wednesday that it has signed a collaborative services agreement with Inaphaea BioLabs - a wholly-owned subsidiary of ValiRx.

Read more
14 Apr 2023 12:34

Physiomics to present work at US cancer research summit

(Sharecast News) - Physiomics announced its participation in the American Association for Cancer Research (AACR) annual meeting on Friday, being held in Orlando on 14-19 April.

Read more
4 Apr 2023 10:47

Physiomics shares drop as laments lack of funding for biotechnology

(Alliance News) - Physiomics PLC on Tuesday announced that its revenue was hampered by pressure resulting from low biotechnology funding.

Read more
4 Apr 2023 10:24

AIM WINNERS & LOSERS: Light Science shares plummet on fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
28 Mar 2023 16:46

TRADING UPDATES: Galantas Gold closes placement; Kropz makes draw down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
10 Mar 2023 12:06

IN BRIEF: Physiomics wins further contract from Bicycle Therapeutics

Physiomics PLC - London-based oncology consultancy, which uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions - Gets a further contract from existing client Bicycle Therapeutics relating to an undisclosed programme. Expects this to be completed in Physiomics's current financial year.

Read more
10 Mar 2023 08:51

Physiomics wins further contract with Bicycle Therapeutics

(Sharecast News) - Oncology consultancy Physiomics revealed on Friday that it had been awarded a further contract by existing client Bicycle Therapeutics.

Read more
7 Mar 2023 17:05

Physiomics confident despite weaker first half

(Sharecast News) - Oncology consultancy firm Physiomics reported revenue of £0.34m in its first half on Tuesday - a slight decrease from the £0.37m reported in the same period a year earlier.

Read more
7 Mar 2023 14:39

EARNINGS SUMMARY: Foxtons profit doubles; Reach yearly profit dips

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Jan 2023 11:17

Physiomics COO Chassagnole changes title to chief scientific officer

(Alliance News) - Physiomics PLC on Friday said Christophe Chassagnole's job title has changed from chief operating officer to chief scientific officer.

Read more
11 Jan 2023 12:04

Physiomics announces another contract with client Cancer Research UK

(Alliance News) - Physiomics PLC on Wednesday said it entered into a further contract with its existing client Cancer Research UK to conduct analyses of a blood cancer treatment.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.